Chronic Disease

Chronic conditions are what most people in the United States will live with and eventually die of. Diabetes, hypertension, heart disease, chronic kidney disease, COPD, obesity, and cancer account for the majority of deaths and the majority of health spending. They are also the conditions in which the gap between what medicine knows and what patients actually experience is widest.

The clinical knowledge is largely settled. What is not settled is delivery. Managing type 2 diabetes well means medication that has to be affordable and refilled, food that has to be available and affordable nearby, movement that requires somewhere safe to do it, sleep that requires stable housing, and appointments that require transportation and time off. Any one of those failing is enough to make an otherwise correct treatment plan fail, and the failure is usually recorded as noncompliance.

This is where chronic disease and equity meet directly. Amputation rates, dialysis initiation, uncontrolled hypertension, and late-stage cancer diagnosis all cluster by race, income, and geography — not because the biology differs but because the conditions for management do. A patient with the same diagnosis and the same physician can have entirely different outcomes depending on whether the pharmacy is open on the weekend.

What works tends to be continuous rather than episodic: care teams rather than solo physicians, community health workers and pharmacists inside the loop, remote monitoring where it is genuinely useful, group visits, peer support, and self-management education that respects what the person already knows about their own body. It also means treating the diagnosis as one part of a life that includes work, family, faith, and cost.

These episodes include clinicians, researchers, educators, and people living with chronic conditions describing what management actually requires — including the parts of the standard advice that do not survive contact with a real week.